CME Group Inc. (CME) Financial Statements
Historical financial data — 42 statements covering FY2016–FY2025
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies,...
CME Group Inc.'s revenue increased 6.4% year over year, from $6.13B to $6.52B.
Net income increased 15.5% over the same period, from $3.53B to $4.07B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 81% in total.
Total debt decreased by 100.0% to $0.
The debt-to-equity ratio stands at 0.00, indicating a conservative leverage profile.
Operating cash flow grew 15.9% to $4.28B.
CME Group Inc. maintains a strong net profit margin of 62.5%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $1.58B+3.4% | $901.3M | $1.02B | $1.02B | $1.00B | $137.80B | $749.7M | $28.22B |
| Q4 FY2024 | $1.53B-3.7% | $908.0M | $947.1M | $947.1M | $1.02B | $137.45B | $749.8M | $26.49B |
| Q1 FY2025 | $1.64B+7.7% | $944.2M | $1.11B | $1.11B | $1.12B | $157.83B | $0 | $27.03B |
| Q2 FY2025 | $1.69B+3.0% | $1.01B | $1.13B | $1.13B | $1.06B | $179.91B | $0 | $27.74B |
| Q3 FY2025 | $1.54B-9.1% | $896.6M | $972.6M | $972.6M | $968.1M | $187.14B | $0 | $28.19B |
| Q4 FY2025 | $1.65B+7.2% | $1.22B | $1.02B | $1.02B | $1.13B | $198.42B | $0 | $28.73B |
| Q1 FY2026 | $1.88B+14.0% | $1.17B | $1.31B | $1.31B | $1.26B | $201.99B | $3.74B | $26.62B |
| Q2 FY2026 | $1.71B-9.2% | $1.03B | $1.11B | $1.11B | $947.1M | $194.68B | $3.87B | $26.52B |
Balance Sheet Summary (Q2 FY2026)
CME Group Inc. (CME) Financial Statements & Revenue History
CME Group Inc. (CME) is a US-listed stock operating in the Financial Services sector, specifically the Security & Commodity Brokers, Dealers, Exchanges & Services industry trading at $293.87 with a market capitalization of $106. This page provides 42 historical financial statements for CME Group Inc., including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, CME Group Inc. reported revenue of $6.5 billion, representing 6.4% year-over-year growth. The net profit margin of 62.5% reflects strong profitability. The debt-to-equity ratio of 0.00 shows conservative leverage.
CME Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows CME Group Inc.'s revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether CME is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track CME's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently CME Group Inc. converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of CME's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use CME Financial Data
Investors use CME Group Inc.'s financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare CME's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how CME's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View CME's financial health score, earnings, and pre-market pricing.
Financial data is sourced from CME Group Inc.'s SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.CME trades on NYSE. This page is for informational purposes only and is not financial advice.